ID OPRX_RAT Reviewed; 367 AA. AC P35370; Q791R4; DT 01-JUN-1994, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-1994, sequence version 1. DT 27-MAR-2024, entry version 163. DE RecName: Full=Nociceptin receptor; DE AltName: Full=Kappa-type 3 opioid receptor; DE Short=KOR-3; DE AltName: Full=Orphanin FQ receptor; DE AltName: Full=ROR-C; DE AltName: Full=XOR1; GN Name=Oprl1; Synonyms=Oor, Oprl; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC STRAIN=Wistar; TISSUE=Brain; RX PubMed=8163014; DOI=10.1016/0014-5793(94)80603-9; RA Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., RA Houtani T., Sugimoto T.; RT "cDNA cloning and regional distribution of a novel member of the opioid RT receptor family."; RL FEBS Lett. 343:42-46(1994). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Hippocampus; RA Meng F., Xie G., Alfred M., Thompson R., Hoversten M., Watson S., Akil H.; RL Submitted (JAN-1994) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC STRAIN=Sprague-Dawley; TISSUE=Brain; RX PubMed=8034019; DOI=10.1016/0014-5793(94)00561-3; RA Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., RA Grandy D.K.; RT "Molecular cloning and tissue distribution of a putative member of the rat RT opioid receptor gene family that is not a mu, delta or kappa opioid RT receptor type."; RL FEBS Lett. 347:284-288(1994). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RX PubMed=8034018; DOI=10.1016/0014-5793(94)00560-5; RA Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C.A., Yu L.; RT "Molecular cloning, tissue distribution and chromosomal localization of a RT novel member of the opioid receptor gene family."; RL FEBS Lett. 347:279-283(1994). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Brain; RX PubMed=7798930; DOI=10.1046/j.1471-4159.1995.64010034.x; RA Lachowicz J.E., Shen Y., Monsma F.J. Jr., Sibley D.R.; RT "Molecular cloning of a novel G protein-coupled receptor related to the RT opiate receptor family."; RL J. Neurochem. 64:34-40(1995). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Brain; RX PubMed=8026588; DOI=10.1016/0014-5793(94)00557-5; RA Wang J.B., Johnson P.S., Imai Y., Persico A.M., Ozenberger B.A., RA Eppler C.M., Uhl G.R.; RT "cDNA cloning of an orphan opiate receptor gene family member and its RT splice variant."; RL FEBS Lett. 348:75-79(1994). RN [7] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=Sprague-Dawley; TISSUE=Brain; RX PubMed=7877452; DOI=10.1016/0169-328x(94)90181-3; RA Wick M.J., Minnerath S.R., Lin X., Elde R.P., Law P.Y., Loh H.H.; RT "Isolation of a novel cDNA encoding a putative membrane receptor with high RT homology to the cloned mu, delta, and kappa opioid receptors."; RL Brain Res. Mol. Brain Res. 27:37-44(1994). RN [8] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY. RX PubMed=11290428; DOI=10.1016/s0378-1119(00)00553-9; RA Curro D., Song I., Anderson M., Yoo J.H., Del Valle J., Owyang C.; RT "Molecular cloning of the orphanin FQ receptor gene and differential tissue RT expression of splice variants in rat."; RL Gene 266:139-145(2001). RN [9] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY. RC STRAIN=Wistar; RX PubMed=15937148; DOI=10.1124/jpet.105.089284; RA Ruiz-Velasco V., Puhl H.L., Fuller B.C., Sumner A.D.; RT "Modulation of Ca2+ channels by opioid receptor-like 1 receptors natively RT expressed in rat stellate ganglion neurons innervating cardiac muscle."; RL J. Pharmacol. Exp. Ther. 314:987-994(2005). RN [10] RP FUNCTION. RX PubMed=18588920; DOI=10.1016/j.regpep.2008.06.001; RA Chen L.Y., Huang J.X., Yu L.C.; RT "Involvement of ORL1 receptor and ERK kinase in the orphanin FQ-induced RT nociception in the nucleus accumbens of rats."; RL Regul. Pept. 151:43-47(2008). CC -!- FUNCTION: G-protein coupled opioid receptor that functions as a CC receptor for the endogenous neuropeptide nociceptin. Ligand binding CC causes a conformation change that triggers signaling via guanine CC nucleotide-binding proteins (G proteins) and modulates the activity of CC down-stream effectors. Signaling via G proteins mediates inhibition of CC adenylate cyclase activity and calcium channel activity. Arrestins CC modulate signaling via G proteins and mediate the activation of CC alternative signaling pathways that lead to the activation of MAP CC kinases. Plays a role in modulating nociception and the perception of CC pain. Plays a role in the regulation of locomotor activity by the CC neuropeptide nociceptin. {ECO:0000269|PubMed:15937148, CC ECO:0000269|PubMed:18588920}. CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC Cytoplasmic vesicle {ECO:0000250}. Note=Ligand binding leads to CC receptor internalization into cytoplasmic vesicles, decreasing the CC amount of available receptor at the cell surface (By similarity). CC Internalization requires phosphorylation at Ser-360. Can recycle to the CC cell membrane. {ECO:0000250}. CC -!- TISSUE SPECIFICITY: Highly expressed in several brain areas, the CC intestine, liver and spleen. Detected in sympathetic stellate ganglion CC neurons. {ECO:0000269|PubMed:11290428, ECO:0000269|PubMed:15937148, CC ECO:0000269|PubMed:7798930, ECO:0000269|PubMed:8026588, CC ECO:0000269|PubMed:8034018, ECO:0000269|PubMed:8034019, CC ECO:0000269|PubMed:8163014}. CC -!- PTM: Phosphorylation at Ser-360 requires GRK3. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D16438; BAA03908.1; -; mRNA. DR EMBL; U05239; AAA16201.1; -; mRNA. DR EMBL; U01913; AAA21025.1; -; mRNA. DR EMBL; L28144; AAC37661.1; -; mRNA. DR EMBL; U07871; AAA69927.1; -; mRNA. DR EMBL; L33916; AAA50827.1; -; mRNA. DR EMBL; L29419; AAC42041.1; -; mRNA. DR EMBL; AF216218; AAF80990.1; -; Genomic_DNA. DR EMBL; AY152731; AAN77720.1; -; mRNA. DR PIR; I56520; I56520. DR RefSeq; NP_113757.1; NM_031569.4. DR RefSeq; XP_006235798.1; XM_006235736.3. DR RefSeq; XP_006235800.1; XM_006235738.3. DR RefSeq; XP_017447001.1; XM_017591512.1. DR RefSeq; XP_017447002.1; XM_017591513.1. DR RefSeq; XP_017447003.1; XM_017591514.1. DR AlphaFoldDB; P35370; -. DR SMR; P35370; -. DR STRING; 10116.ENSRNOP00000047053; -. DR BindingDB; P35370; -. DR ChEMBL; CHEMBL4503; -. DR GuidetoPHARMACOLOGY; 320; -. DR GlyCosmos; P35370; 3 sites, No reported glycans. DR GlyGen; P35370; 3 sites. DR iPTMnet; P35370; -. DR PhosphoSitePlus; P35370; -. DR PaxDb; 10116-ENSRNOP00000047053; -. DR Ensembl; ENSRNOT00000045845.4; ENSRNOP00000047053.1; ENSRNOG00000016768.8. DR Ensembl; ENSRNOT00055002097; ENSRNOP00055001632; ENSRNOG00055001262. DR Ensembl; ENSRNOT00060002205; ENSRNOP00060001392; ENSRNOG00060001471. DR Ensembl; ENSRNOT00065023194; ENSRNOP00065018063; ENSRNOG00065014024. DR GeneID; 29256; -. DR KEGG; rno:29256; -. DR UCSC; RGD:68438; rat. DR AGR; RGD:68438; -. DR CTD; 4987; -. DR RGD; 68438; Oprl1. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT00940000160661; -. DR HOGENOM; CLU_009579_8_1_1; -. DR InParanoid; P35370; -. DR OMA; VNICIWA; -. DR OrthoDB; 5393360at2759; -. DR PhylomeDB; P35370; -. DR TreeFam; TF315737; -. DR Reactome; R-RNO-375276; Peptide ligand-binding receptors. DR Reactome; R-RNO-418594; G alpha (i) signalling events. DR PRO; PR:P35370; -. DR Proteomes; UP000002494; Chromosome 3. DR Bgee; ENSRNOG00000016768; Expressed in frontal cortex and 4 other cell types or tissues. DR ExpressionAtlas; P35370; baseline and differential. DR GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW. DR GO; GO:0043005; C:neuron projection; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB. DR GO; GO:0097060; C:synaptic membrane; ISO:RGD. DR GO; GO:0004930; F:G protein-coupled receptor activity; ISS:UniProtKB. DR GO; GO:0042923; F:neuropeptide binding; IBA:GO_Central. DR GO; GO:0001626; F:nociceptin receptor activity; ISS:UniProtKB. DR GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; ISS:UniProtKB. DR GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD. DR GO; GO:1990708; P:conditioned place preference; IMP:RGD. DR GO; GO:0042755; P:eating behavior; IMP:RGD. DR GO; GO:0044849; P:estrous cycle; IEP:RGD. DR GO; GO:0106072; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:RGD. DR GO; GO:0045776; P:negative regulation of blood pressure; IMP:RGD. DR GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IMP:RGD. DR GO; GO:0007270; P:neuron-neuron synaptic transmission; ISO:RGD. DR GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central. DR GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISO:RGD. DR GO; GO:0035810; P:positive regulation of urine volume; IDA:RGD. DR GO; GO:1904059; P:regulation of locomotor rhythm; IMP:RGD. DR GO; GO:0032355; P:response to estradiol; IEP:RGD. DR GO; GO:0019233; P:sensory perception of pain; ISS:UniProtKB. DR CDD; cd15092; 7tmA_NOFQ_opioid_R; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR001418; Opioid_rcpt. DR InterPro; IPR001420; X_opioid_rcpt. DR PANTHER; PTHR24229; NEUROPEPTIDES RECEPTOR; 1. DR PANTHER; PTHR24229:SF11; NOCICEPTIN RECEPTOR; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00237; GPCRRHODOPSN. DR PRINTS; PR00384; OPIOIDR. DR PRINTS; PR00547; XOPIOIDR. DR SMART; SM01381; 7TM_GPCR_Srsx; 1. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; P35370; RN. PE 2: Evidence at transcript level; KW Behavior; Cell membrane; Cytoplasmic vesicle; Disulfide bond; KW G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane; Palmitate; KW Phosphoprotein; Receptor; Reference proteome; Transducer; Transmembrane; KW Transmembrane helix. FT CHAIN 1..367 FT /note="Nociceptin receptor" FT /id="PRO_0000069983" FT TOPO_DOM 1..45 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 46..71 FT /note="Helical; Name=1" FT /evidence="ECO:0000250" FT TOPO_DOM 72..84 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 85..106 FT /note="Helical; Name=2" FT /evidence="ECO:0000250" FT TOPO_DOM 107..121 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 122..143 FT /note="Helical; Name=3" FT /evidence="ECO:0000250" FT TOPO_DOM 144..162 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 163..185 FT /note="Helical; Name=4" FT /evidence="ECO:0000250" FT TOPO_DOM 186..208 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 209..233 FT /note="Helical; Name=5" FT /evidence="ECO:0000250" FT TOPO_DOM 234..261 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 262..282 FT /note="Helical; Name=6" FT /evidence="ECO:0000250" FT TOPO_DOM 283..297 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 298..319 FT /note="Helical; Name=7" FT /evidence="ECO:0000250" FT TOPO_DOM 320..367 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT SITE 107 FT /note="Important for G protein-mediated signaling" FT /evidence="ECO:0000250" FT SITE 127 FT /note="Important for G protein-mediated signaling" FT /evidence="ECO:0000250" FT LIPID 331 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000255" FT CARBOHYD 21 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 26 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 36 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 120..197 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT CONFLICT 105 FT /note="G -> R (in Ref. 2; AAA16201)" FT /evidence="ECO:0000305" FT CONFLICT 226 FT /note="L -> V (in Ref. 2; AAA16201)" FT /evidence="ECO:0000305" FT CONFLICT 246 FT /note="S -> P (in Ref. 2; AAA16201)" FT /evidence="ECO:0000305" FT CONFLICT 348 FT /note="S -> T (in Ref. 3)" FT /evidence="ECO:0000305" SQ SEQUENCE 367 AA; 40523 MW; EB2637582747B4AD CRC64; MESLFPAPYW EVLYGSHFQG NLSLLNETVP HHLLLNASHS AFLPLGLKVT IVGLYLAVCI GGLLGNCLVM YVILRHTKMK TATNIYIFNL ALADTLVLLT LPFQGTDILL GFWPFGNALC KTVIAIDYYN MFTSTFTLTA MSVDRYVAIC HPIRALDVRT SSKAQAVNVA IWALASVVGV PVAIMGSAQV EDEEIECLVE IPAPQDYWGP VFAICIFLFS FIIPVLIISV CYSLMIRRLR GVRLLSGSRE KDRNLRRITR LVLVVVAVFV GCWTPVQVFV LVQGLGVQPG SETAVAILRF CTALGYVNSC LNPILYAFLD ENFKACFRKF CCASSLHREM QVSDRVRSIA KDVGLGCKTS ETVPRPA //